What You Should Know:
– Early detection and treatment of post-stroke spasticity (PSS) are essential for improving a patient’s ability to function and overall quality of life after a stroke.
– To address this need, AbbVie…
Continue Reading
Background: Early detection of cognitive impairment or dementia is essential to reduce the incidence of severe neurodegenerative diseases. However, currently available diagnostic tools for detecting mild cognitive impairment (MCI) or dementia are time-consuming, expensive,…
Continue Reading
Gait impairments are among the most common and disabling symptoms of Parkinson’s disease and worsen as the disease progresses. Early detection and diagnosis of subtype-specific gait deficits, as well as progression monitoring, can help…
Continue Reading
Australia has one of the world’s highest levels of ultraviolet radiation, a proven carcinogen that causes skin care and eye diseases. UV damage is said to accumulate from childhood, and the risk of developing…
Continue Reading
What You Should Know:
– Cancer – the second leading cause of death in the United States – is a complex disease requiring timely diagnosis and treatment. Delays in either can significantly impact patient outcomes.
–…
Continue Reading
What You Should Know:
– Relapse rates in behavioral health treatment are a persistent hurdle. Up to 80% of people with substance use disorders will relapse at some point, causing discouragement for both patients and…
Continue Reading
What You Should Know:
– A new study by Phreesia and the National Kidney Foundation (NKF) reveals a troubling gap in awareness of chronic kidney disease (CKD) among high-risk patients. Published in The American Journal…
Continue Reading
Nano-X Imaging, a pioneering company in the field of medical imaging technology, has taken a significant leap forward by integrating artificial intelligence (AI) functionality into its Second Opinions online medical consultation service. This innovative…
Continue Reading
What You Should Know:
– Eko Health, a leader in AI-powered early detection of heart and lung diseases, announced today a successful Series D financing round of $41 million.
– This funding, led by ARTIS Ventures,…
Continue Reading
What You Should Know: – AvaSure, a leader in acute virtual care, and CLEW Medical, specializing in AI-driven clinical surveillance and predictive analytics, have partnered to enhance early detection of critical care patient deterioration,…
Continue Reading
